New approach to implantable cardioverter-defibrillators in small pediatric patients: Dorsal positioning of superior vena cava shock lead in a 3-year-old  by Pedersen, Susanne Bendesgaard et al.
Surgical Techniquesthe patient who died early in our study, the left, larger SVC
was anastomosed to the right smaller SVC considering the
anastomosis side of the Fontan conduit, because the IVC
was positioned on the same side as the smaller SVC. This
led to the elevation of the central venous pressure, and
severe edema of the face was observed postoperatively.
Second, if the length of the SVC is too short to anastomose,
the time to perform the anastomosis with our new procedure
should be similar to that of the bilateral bidirectional
Glenn procedure. Third, the new innominate vein may be
compressed from the posterior side, because the aortic
arch was placed anteriorly with transposition of the
great arteries. We had seen only a single case with
apicocaval juxtaposition. We created the unifocalized
SVC on the left side, because the route of the conduit wasFrom the Departments of Cardiologya and Thoracic Surgery,bAarhus University
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The postoperative course after the Fontan procedure in
this patient was uneventful and satisfactory. This new
surgical method of SVC unifocalization, would be effective
in the staged Glenn procedure for patients with bilateral
SVC.References
1. Xu YQ, Liu YL, L€u XD, Li YQ, Yu CT. Bilateral bidirectional superior
cavopulmonary shunt is more beneficial in medium and long term clinical
outcome than unilateral shunt. Chin Med J. 2009;122:129-35.
2. de Zelicourt DA, Pekkan K, Parks J, Kanter K, Fogel M, Yoganathan AP.
Flow study of an extracardiac connection with persistent left superior vena
cava. J Thorac Cardiovasc Surg. 2006;131:785-91.
3. Srivastava D, Preminger T, Lock JE, Mandell V, Keane JF, Mayer JE Jr, et al.
Hepatic venous blood and the development of pulmonary arteriovenous
malformations in congenital heart disease. Circulation. 1995;92:1217-22.New approach to implantable cardioverter-defibrillators in small
pediatric patients: Dorsal positioning of superior vena cava shock
lead in a 3-year-oldSusanne Bendesgaard Pedersen, MD,a Morten Holdgaard Smerup, MD, PhD,b and
Jens Cosedis Nielsen, MD, DMSc,a Skejby, DenmarkVideo clip is available online.
The use of implantable cardioverter-defibrillators (ICDs) in
pediatric patients is increasing, and the average age at
implantation is decreasing.1 Because the constraints of
vascular and thoracic anatomy necessitate the adaptation
of existing systems, which were developed for and tested
in adults,2 ICD implantation in pediatric patients remains
a challenging procedure. Device-related complications
occur in more than 10% of the pediatric ICD recipient
population,3 and the effectiveness of shock therapy varies,4emphasizing the importance of optimal lead and device
positioning in such patients.
CLINICAL SUMMARY
A 3-year-old boy with a history of exertional or
emotionally triggered syncopes was resuscitated from out-
of-hospital cardiac arrest with ventricular fibrillation. No
structural heart disease was found. One month later, a
single-chamber ICD (St Jude Medical Ellipse; St Jude
Medical, Inc, St Paul, Minn) was implanted. Because of
the patient’s size (height of 97 cm and weight of 15.8 kg)
and the prospect of several reimplantations during his entire
life span, neither a transvenous nor an epicardial approach
for shock lead implantation was considered optimal.
Instead, we chose an alternative approach. The ICD
generator pocket was created under the rectus muscle in
the upper left abdomen. A superior vena cava shock lead
(Medtronic Transvene CS/SVC 6937 A; Medtronic, Inc,
Fridley, Minn) was implanted subcutaneously in a dorsal
position left to the upper thoracic spine and connected to
the abdominal generator through a subcutaneous tunnel
(Figure 1). This lead was fixed with sutures at its distal
end, before its course under the costal margin, and as it
entered the abdominal pocket. An epicardial lead
(Medtronic CapSure EPI 4968; Medtronic, Inc, Fridley,ery c July 2014
FIGURE 1. The diagram illustrates the patient’s position on the operating room table and the incisions made for implantation of the implantable
cardioverter-defibrillator. SVC, Superior vena cava shock lead; EPI, epicardial lead; ICD, implantable cardioverter-defibrillator generator.
Surgical TechniquesMinn) for pacing and sensing was placed through a lateral
minithoracotomy. The patient underwent successful
defibrillation threshold testing. The ICD was set to detect
ventricular fibrillation at a rate greater than 240 beats/min
for 40 intervals and to defibrillate with an energy of first
1 3 21 J, then 1 3 26 J, and finally 4 3 31 J. FluoroscopyFIGURE 2. Combined images from the postprocedural fluoroscopy
illustrating the superior vena cava shock lead in a dorsal position and the
epicardial lead for ventricular sensing and pacing. Video 1 depicts
the full-length fluoroscopy. SVC, Superior vena cava shock lead;
EPI, epicardial lead; ICD, implantable cardioverter-defibrillator generator.
The Journal of Thoracic and Caafter 3 days confirmed the lead placement (Figure 2,
Video 1), and routine testing of the device revealed
satisfactory electrical parameters. The patient was dis-
charged from the hospital 4 days after ICD implantation.
While hiding in a wardrobe during a game of hide-and-
seek 3 weeks after his discharge, the patient had a new
episode of ventricular fibrillation. This episode was
initiated by polymorphic ventricular extrasystolia and was
successfully terminated by the ICD with a single shock of
21 J. The patient recovered immediately. The patient’s
genetic test results did not reveal any mutations known to
be associated with the development of cardiac arrhythmias.DISCUSSION
In this case of assumed catecholaminergic polymorphic
ventricular tachycardia, we introduced a new technique
for ICD implantation in small pediatric patients. This
approach was chosen after careful consideration of the other
available options.
To avoid having to place a long, rigid standard shock
lead in a thin-walled child-sized right ventricle, we
chose not to use a transvenous approach. Furthermore,
preservation of the veins for later transvenous shock
lead implantation was made a priority. Implantation of
a standard subcutaneous shock lead in the dorsal position
was eschewed because of the stiffness and size of this
lead (10F), and also because the length of the shock
coil could potentially pull the defibrillation field inferior
to the heart. Existing models of the subcutaneous ICD
were judged too large for implantation in such a small
pediatric patient. We found it unattractive to implant a
standard shock lead in the epicardium, because this
would have required more extensive surgery and left a
defibrillation lead that would be difficult to remove in
later years.
During this patient’s follow-up and growth, special
attention will be given to the relationship betweenrdiovascular Surgery c Volume 148, Number 1 359
Surgical Techniquesthe heart and the defibrillation field. Repeated defi-
brillation testing may be indicated, and shock lead
replacement with a standard subcutaneous shock lead will
be considered.
In conclusion, ICD implantation with dorsal positioning
of a subcutaneous superior vena cava shock lead is an option
for small pediatric patients. It can be established with less
extensive surgery and protects against sudden death while
preserving the veins and the right ventricular endocardium
for later use.360 The Journal of Thoracic and Cardiovascular SurgReferences
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